EyePoint Pharmaceuticals (NASDAQ:EYPT) just reported results for the first quarter of 2024.
- EyePoint Pharmaceuticals reported earnings per share of -55 cents. This was below the analyst estimate for EPS of -42 cents.
- The company reported revenue of $11.68 million.
- This was 17.78% better than the analyst estimate for revenue of $9.92 million.